Literature DB >> 21516693

[Clinical guides for immunoglobulin A (IgA) nephropathy in Japan, third version].

.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21516693

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN： 0385-2385


× No keyword cloud information.
  13 in total

1.  Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.

Authors:  Takahito Moriyama; Kayu Nakayama; Ayami Ochi; Nobuyuki Amemiya; Yuki Tsuruta; Chiari Kojima; Mitsuyo Itabashi; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-10-26       Impact factor: 2.801

2.  Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy.

Authors:  Yoshikuni Nagayama; Hiroki Nishiwaki; Takeshi Hasegawa; Daisuke Komukai; Eri Kawashima; Mamiko Takayasu; Hironori Tayama; Yoshihiko Inoue; Kiyoko Inui; Ashio Yoshimura
Journal:  Clin Exp Nephrol       Date:  2014-11-07       Impact factor: 2.801

3.  Comparison of methods of steroid administration combined with tonsillectomy for IgA nephropathy patients.

Authors:  Hirofumi Watanabe; Shin Goto; Daisuke Kondo; Takuma Takata; Hajime Yamazaki; Michihiro Hosojima; Suguru Yamamoto; Yoshikatsu Kaneko; Ryuji Aoyagi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2016-05-23       Impact factor: 2.801

4.  Restructuring the Ikeda City school urinary screening system: report of a screening survey.

Authors:  Nobuyuki Kajiwara; Kazuyuki Hayashi; Takayuki Fukui; Satoko Yamamoto; Kensuke Senzaki; Shinichiro Murakami; Takuya Kitamura; Takato Ueoka; Mikito Inoue; Shigeki Hayashi; Keiko Sakamoto; Maiko Yoshimoto; Seiko Asano; Ichiro Maki
Journal:  Asia Pac Fam Med       Date:  2013-12-13

5.  Significance of urinary full-length megalin in patients with IgA nephropathy.

Authors:  Takuto Seki; Katsuhiko Asanuma; Rin Asao; Kanae Nonaka; Yu Sasaki; Juan Alejandro Oliva Trejo; Hiroyuki Kurosawa; Yoshiaki Hirayama; Satoshi Horikoshi; Yasuhiko Tomino; Akihiko Saito
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

6.  A case of immunoglobulin A nephropathy treated successfully with tonsillectomy and steroid pulse therapy 20 years after onset.

Authors:  Jumpei Hasegawa; Kei Yamada; Yoshie Kaga; Yasutomo Abe; Mariko Endo; Sachiko Wakai
Journal:  CEN Case Rep       Date:  2013-07-03

7.  Five cases of tonsillectomy and steroid pulse therapy for recurrent immunoglobulin A nephropathy after kidney transplantation.

Authors:  Yoshie Hoshino; Yasutomo Abe; Mariko Endo; Sachiko Wakai; Hiroki Shirakawa; Osamu Hotta; Hideki Ishida; Kazunari Tanabe; Ken Tsuchiya; Kosaku Nitta
Journal:  CEN Case Rep       Date:  2013-09-12

8.  The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial.

Authors:  Takahito Moriyama; Saeko Kumon; Takahiro Kamiyama; Kazunori Karasawa; Keiko Uchida; Kosaku Nitta
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

9.  Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.

Authors:  Ritsuko Katafuchi; Tetsuya Kawamura; Kensuke Joh; Akinori Hashiguchi; Satoshi Hisano; Akira Shimizu; Yoichi Miyazaki; Masaharu Nagata; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-09-09       Impact factor: 2.801

10.  Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy.

Authors:  Shuntaro Maruyama; Tomohito Gohda; Yusuke Suzuki; Hitoshi Suzuki; Yuji Sonoda; Saki Ichikawa; Zi Li; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Kidney Res Clin Pract       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.